Financial Advisory Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Financial Advisory Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,873	Closed	-$270K	–	89
2022 Q1	$270K	Buy	5,873 +35	+0.6%	+$1.67K	0.05%	77
2021 Q4	$358K	Hold	5,838	–	–	0.07%	69
2021 Q3	$436K	Hold	5,838	–	–	0.1%	58
2021 Q2	$540K	Hold	5,838	–	–	0.13%	51
2021 Q1	$518K	Sell	5,838 -27	-0.5%	-$2.68K	0.13%	51
2020 Q4	$547K	Buy	5,865 +2,295	+64%	+$183K	0.14%	48
2020 Q3	$227K	Buy	+3,570	New	+$209K	0.07%	69

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Financial Advisory Group's ARKG Position: Q2 2022 in Review

Financial Advisory Group sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 5,873 shares — an estimated $270K sold.

Financial Advisory Group first reported a position in ARKG in Q3 2020 and held it in 7 quarters. The position peaked at $547K in Q4 2020. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Financial Advisory Group reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
Financial Advisory Group sold 5,873 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $270K.
Financial Advisory Group first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 7 quarters.
Financial Advisory Group's ARK Genomic Revolution ETF position peaked at $547K in Q4 2020.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Financial Advisory Group's 13F filing for Q2 2022, filed 10 Aug 2022.